A comparison between the effects of BMS-180448, a novel K+ channel opener, and cromakalim in rat and dog

scientific article published on 01 December 1995

A comparison between the effects of BMS-180448, a novel K+ channel opener, and cromakalim in rat and dog is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/0014-2999(95)00543-9
P698PubMed publication ID8788441

P2093author name stringG J Grover
P G Sleph
A J D'Alonzo
J C Sewter
R B Darbenzio
T A Hess
N J Lodge
D E Normandin
P433issue1
P407language of work or nameEnglishQ1860
P304page(s)271-280
P577publication date1995-12-01
P1433published inEuropean Journal of PharmacologyQ1376712
P1476titleA comparison between the effects of BMS-180448, a novel K+ channel opener, and cromakalim in rat and dog
P478volume294

Reverse relations

cites work (P2860)
Q44454521Cardioselective anti-ischemic ATP-sensitive potassium channel (KATP) openers: benzopyranyl indoline and indole analogues
Q40650417Identification of a novel antiangiogenic agent; 4-(N-imidazol-2-ylmethyl)amino benzopyran analogues
Q33960965K(+) channels as therapeutic drug targets
Q53910296The antihypertensive and cardioprotective effects of (-)-MJ-451, an ATP-sensitive K(+) channel opener
Q71737283The novel cardioprotective agent BMS-180448 activates a potassium conductance in cardiac and vascular smooth muscle

Search more.